{
    "2021-02-28": [
        [
            {
                "time": "",
                "original_text": "天风证券给予华熙生物买入评级，功能性护肤品带动营收高增长超预期，业务板块全面开花锚定长期业绩",
                "features": {
                    "keywords": [
                        "华熙生物",
                        "买入评级",
                        "功能性护肤品",
                        "营收高增长",
                        "业务板块全面开花",
                        "长期业绩"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "消费品"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}